SCHEMBL5077969

SCHEMBL5077969

CC1CNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24619019 1.00
SCHEMBL20841336 1.00
SCHEMBL867968 0.81
SCHEMBL29332611 0.81
SCHEMBL7624170 0.79 CRBN (0.32)
SCHEMBL22175597 0.77 CRBN (0.31)
SCHEMBL25838009 0.77
SCHEMBL17826592 0.75
SCHEMBL48294 0.75
SCHEMBL29626444 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 US claimed
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 US claimed
EP-0509821-B1 Substituted acetoxyazetidinone derivatives and process for preparing 4-acyloxyazetidinone derivatives TAKASAGO PERFUMERY CO LTD (JP) 1995-12-27 EP claimed
EP-0509821-A1 Substituted acetoxyazetidinone derivatives and process for preparing 4-acyloxyazetidinone derivatives Takasago International Corporation (JP) 1992-10-21 EP claimed
CN-118019737-A Beta-lactam derivatives for the treatment of diseases 英矽智能科技知识产权有限公司 2024-05-10 CN disclosed
US-20230192667-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES INSILICO MEDICINE IP LIMITED (HK) 2023-06-22 US disclosed
US-9771321-B2 Small molecules that covalently modify transthyretin THE SCRIPPS RESEARCH INSTITUTE (US) 2017-09-26 US disclosed
US-20170190660-A9 Small Molecules That Covalently Modify Transthyretin KELLY JEFFERY W (US) 2017-07-06 US disclosed
US-20160257706-A1 Beta-D-2'-DEOXY-2'-alpha-FLUORO-2'-beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT Atea Pharmaceuticals, Inc. (US) 2016-09-08 US disclosed
US-20160152674-A1 TDF-RELATED COMPOUNDS AND ANALOGS THEREOF THRASOS INNOVATION, INC. (CA) 2016-06-02 US disclosed
EP-2343069-B1 Heterocyclic aspartyl protease inhibitors MERCK SHARP & DOHME (US) 2016-03-02 EP disclosed
US-9181301-B2 TDF-related compounds and analogs thereof THRASOS INNOVATION, INC. (CA) 2015-11-10 US disclosed
US-5288862-A Reacting azetidinone or derivative with carboxylic acid in presence of ruthenium compound, aldehyde, oxygen TAKASAGO INTERNATIONAL CORPORATION (JP) 1994-02-22 US disclosed
US-5204460-A Reacting azetidinone compound with acetic acid and oxidizing agent in the presence of ruthenium catalyst TAKASAGO INTERNATIONAL CORPORATION (JP) 1993-04-20 US disclosed
US-5191076-A Penicillin intermediates TAKASAGO INTERNATIONAL CORPORATION (JP) 1993-03-02 US disclosed
EP-0509821-A1 Substituted acetoxyazetidinone derivatives and process for preparing 4-acyloxyazetidinone derivatives Takasago International Corporation (JP) 1992-10-21 EP disclosed
EP-0488611-A1 Process for producing 4-acetoxyazetidinones Takasago International Corporation (JP) 1992-06-03 EP disclosed
US-5081239-A Reacting an azetidinone with acetic acid and an oxidizer TAKASAGO INTERNATIONAL CORPORATION (JP) 1992-01-14 US disclosed
EP-0371875-A2 Process for preparing 4-acetoxyazetidinones Takasago International Corporation (JP) 1990-06-06 EP disclosed
US-4683303-A Reduction process for the preparation of 4-unsubstituted azetidin-2-ones PFAENDLER HANS R (DE) 1987-07-28 US disclosed